Concepedia

Bo Tong

BT

14

Publications

669

Citations

14

H-Index

2008

Active since

Affiliations

AbbVie (United States)(Current)

The University of Texas MD Anderson Cancer Center

Cincinnati Children's Hospital Medical Center

St. Jude Children's Research Hospital

University of California, San Francisco

Bo Tong is an author at AbbVie (United States) specializing in medicine, radiation oncology, and cancer research.

ORCID

Top concepts

Publications per year

2008–2021

14

Publications

14

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Vinod Pullarkat, Norman J. Lacayo, Elias Jabbour et al. · Cancer Discovery · 2021 · 270 citations · Full text

Safety, Efficacy, and Patient-Reported Outcomes of Venetoclax in Combination with Azacitidine for the Treatment of Patients with Higher-Risk Myelodysplastic Syndrome: A Phase 1b Study

Jacqueline S. Garcia, Andrew H. Wei, Uma Borate et al. · Blood · 2020 · 58 citations

Optimal Configuration of Hybrid AC/DC Distribution Network Considering the Temporal Power Flow Complementarity on Lines

Lu Zhang, Bo Tong, Zhaoqi Wang et al. · IEEE Transactions on Smart Grid · 2021 · 45 citations

, , +14

Venetoclax in Combination with Gilteritinib in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Phase 1b Study

Alexander E. Perl, Naval Daver, Keith W. Pratz et al. · Blood · 2019 · 41 citations

Epigenetic downregulated ITGBL1 promotes non-small cell lung cancer cell invasion through Wnt/PCP signaling

Xin Gan, Zhentian Liu, Bo Tong et al. · Tumor Biology · 2015 · 39 citations

Rows per page

1–5 of 14